Preliminary results announced by press release include a slight improvement in response and durable CR rates specifically in liver GVHD and gastrointestinal GVHD steroid-refractory patients and an overall trend of better response rates in pediatric patients [ 73 ].
← all excerpts
Human mesenchymal stromal cell-mediated immunoregulation: mechanisms of action and clinical applications.
1
—
—